Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.
Clinical trial NCT03541083 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03541083
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-04
- Primary completion
- 2020-11-30
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.